Literature DB >> 16488070

Post resuscitation care: what are the therapeutic alternatives and what do we know?

J Herlitz1, M Castren, H Friberg, J Nolan, M Skrifvars, K Sunde, P-A Steen.   

Abstract

A large proportion of deaths in the Western World are caused by ischaemic heart disease. Among these patients a majority die outside hospital due to sudden cardiac death. The prognosis among these patients is in general, poor. However, a significant proportion are admitted to a hospital ward alive. The proportion of patients who survive the hospital phase of an out of hospital cardiac arrest varies considerably. Several treatment strategies are applicable during the post resuscitation care phase, but the level of evidence is weak for most of them. Four treatments are recommended for selected patients based on relatively good clinical evidence: therapeutic hypothermia, beta-blockers, coronary artery bypass grafting, and an implantable cardioverter defibrillator. The patient's cerebral function might influence implementation of the latter two alternatives. There is some evidence for revascularisation treatment in patients with suspected myocardial infarction. On pathophysiological grounds, an early coronary angiogram is a reasonable alternative. Further randomised clinical trials of other post resuscitation therapies are essential.

Entities:  

Mesh:

Year:  2006        PMID: 16488070     DOI: 10.1016/j.resuscitation.2005.08.006

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

Review 1.  Recent advances and controversies in adult cardiopulmonary resuscitation.

Authors:  Wanis H Ibrahim
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

2.  A national analysis of the relationship between hospital factors and post-cardiac arrest mortality.

Authors:  Brendan G Carr; Munish Goyal; Roger A Band; David F Gaieski; Benjamin S Abella; Raina M Merchant; Charles C Branas; Lance B Becker; Robert W Neumar
Journal:  Intensive Care Med       Date:  2008-10-21       Impact factor: 17.440

3.  A geospatial assessment of transport distance and survival to discharge in out of hospital cardiac arrest patients: Implications for resuscitation centers.

Authors:  Michael T Cudnik; Robert H Schmicker; Christian Vaillancourt; Craig D Newgard; James M Christenson; Daniel P Davis; Robert A Lowe
Journal:  Resuscitation       Date:  2010-02-01       Impact factor: 5.262

4.  Strict versus moderate glucose control after resuscitation from ventricular fibrillation.

Authors:  Tuomas Oksanen; Markus B Skrifvars; Tero Varpula; Anne Kuitunen; Ville Pettilä; Jouni Nurmi; Maaret Castrén
Journal:  Intensive Care Med       Date:  2007-10-11       Impact factor: 17.440

5.  Effect of methylene blue on the genomic response to reperfusion injury induced by cardiac arrest and cardiopulmonary resuscitation in porcine brain.

Authors:  Cécile Martijn; Lars Wiklund
Journal:  BMC Med Genomics       Date:  2010-07-01       Impact factor: 3.063

6.  Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest.

Authors:  Sigrid Beitland; Bård Endre Waldum-Grevbo; Espen Rostrup Nakstad; Jens-Petter Berg; Anne-Marie Siebke Trøseid; Berit Sletbakk Brusletto; Cathrine Brunborg; Geir Øystein Andersen; Kjetil Sunde
Journal:  Crit Care       Date:  2016-10-05       Impact factor: 9.097

7.  Cognitive impairment after sudden cardiac arrest.

Authors:  Magdalena Jaszke-Psonka; Magdalena Piegza; Piotr Ścisło; Robert Pudlo; Jacek Piegza; Karina Badura-Brzoza; Aleksandra Leksowska; Robert T Hese; Piotr W Gorczyca
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-12-30

8.  Improved survival of hospitalized patients with cardiac arrest due to coronary heart disease after implementation of post-cardiac arrest care: A population-based study.

Authors:  Yu Lin; Shih-Hung Tsai; Chen-Shu Yang; Chun-Hsien Wu; Chih-Han Huang; Fu-Huang Lin; Chih-Hung Ku; Chi-Hsiang Chung; Wu-Chien Chien; Chung-Yu Lai; Chi-Ming Chu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.